文献速递神经肿瘤

基于临床因素与磁共振成像影像组学的弥漫性胶质瘤预后研究

A Study on Prognosis of Diffuse Glioma Based on Clinical Factors and Magnetic Resonance Imaging Radiomics.
PubMed 文献 · World Neurosurg · 2024-04-05

该研究回顾性收集266例经病理确诊的弥漫性胶质瘤患者的术前磁共振成像与临床数据,按训练队列与验证队列7:3比例建模,构建影像组学预后模型、临床因素预后模型及融合模型。验证队列中融合模型的c-index为0.814,1年与3年曲线下面积分别为0.836与0.963,并可区分低风险与高风险组,基于该模型构建的预后计算器可辅助临床评估预后。

要点

  • 验证队列中融合模型c-index为0.814,高于影像组学模型的0.742与临床模型的0.796。
  • 验证队列融合模型1年曲线下面积为0.836,3年曲线下面积为0.963。
  • 融合模型在训练队列、验证队列、全部队列及不同级别胶质瘤队列中均可区分低风险与高风险组。

核心结论

  • 三种模型中融合模型(影像组学联合临床因素)预测效能最优,可更准确评估弥漫性胶质瘤预后。
  • 基于融合模型构建的弥漫性胶质瘤预后计算器可帮助临床医生更简便、准确地评估患者预后,从而制定更合理的治疗策略。

研究设计与样本

  • 回顾性收集266例经病理确诊的弥漫性胶质瘤患者的术前磁共振成像与临床数据,训练队列与验证队列比例为7:3。
  • 构建基于影像组学特征的影像组学预后模型(R-model)、基于临床因素的预后模型(C-model)及融合模型(F-model)。
  • 基于三种模型中的最优模型构建列线图,并据此构建弥漫性胶质瘤预后计算器。

主要发现

  • 验证队列中R-model、C-model、F-model的c-index分别为0.742、0.796、0.814。
  • 验证队列中R-model、C-model、F-model的1年曲线下面积分别为0.749、0.806、0.836。
  • 验证队列中R-model、C-model、F-model的3年曲线下面积分别为0.896、0.966、0.963。
  • 在训练队列、验证队列、全部队列及不同级别胶质瘤队列中,F-model(最优模型)均可较好识别低风险组与高风险组。
  • 弥漫性胶质瘤预后计算器可在https://github.com/HDCurry/prognosis获取。

临床怎么用

  • 作者认为基于融合模型构建的弥漫性胶质瘤预后计算器可辅助临床医生更简便、准确地评估弥漫性胶质瘤患者预后,从而制定更合理的治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To construct an optimal prognostic model to assess the prognosis of patients with diffuse glioma. METHODS: Preoperative magnetic resonance imaging and clinical data were retrospectively collected from 266 patients (training cohort: validation cohort=7:3) with pathologically confirmed diffuse gliomas. A radiomics prognostic model (R-model) based on the radiomics features was constructed. A prognostic model based on clinical factors (C-model) and a fusion model (F-model) was also constructed. Based on the optimal model of three models, the nomogram was constructed. Finally, a "Prognosis Calculator for Diffuse Glioma" was constructed based on the nomogram. RESULTS: The c-index of the R-, C-, and F-models in the validation cohort was 0.742, 0.796, and 0.814, respectively. In the validation cohort, the 1-year area under the curve of the R-, C-, and F-models was 0.749, 0.806, and 0.836, respectively; the 3-year area under the curve was 0.896, 0.966, and 0.963, respectively. In the training cohort, validation cohort, all cohorts, and different grades of glioma cohorts, F-model (optimal model) could identify low- and high-risk groups well. The "Prognosis Calculator for Diffuse Glioma" was available at https://github.com/HDCurry/prognosis. CONCLUSIONS: Among the three models, the F-model (radiomics combined with clinical factors) had optimal predictive efficacy and could more accurately assess the prognosis of diffuse glioma. The "Prognosis Calculator for Diffuse Glioma" constructed based on this model could assist clinicians in more easily and accurately assessing the prognosis of patients with diffuse glioma, thus enabling them to make more reasonable treatment strategies.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Huang D, Gao T, Zhang Y, et al. A Study on Prognosis of Diffuse Glioma Based on Clinical Factors and Magnetic Resonance Imaging Radiomics. World Neurosurg. 2024. PMID: 38583562. doi:10.1016/j.wneu.2024.03.166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。